CUV 3.31% $13.73 clinuvel pharmaceuticals limited

anyone else see the august presentation, page-2

  1. 3,045 Posts.
    Check out the follow up interview, seems on track especially given Phase I in the US is due for completion by December and Phase III trials there after.

    I don't see anything negative, perhaps some posters that know the stock better can look for hints on progress. This time next year it should be a different company.

    I'm holding.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$13.73
Change
-0.470(3.31%)
Mkt cap ! $687.3M
Open High Low Value Volume
$14.00 $14.00 $13.69 $929.6K 67.35K

Buyers (Bids)

No. Vol. Price($)
1 2000 $13.73
 

Sellers (Offers)

Price($) Vol. No.
$13.74 169 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.